EUVIMEDEUVIMED entdecken
Validierungsstudie

Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma

Yuhong He, Shihao Wu, Lifan Chen, Wenxia Chen, Xiumei Zhan, Jiaxing Li, Bingyuan Wang, Chenfeng Gao, Jiayuan Wu, Qingwei Wang, Mingyi Li, Bin Liu

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150633 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Yuhong He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China; Hepatobiliary Rela…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Apoptosis, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study aimed to develop a prognostic model for Hepatocellular Carcinoma (HCC) based on pan-apoptosis-related genes, a novel inflammatory programmed cell death form intricately linked to HCC progression. Utilizing transcriptome sequencing and clinical data from the TCGA database, we identified six crucial pan-apoptosis-related genes through statistical analyses. These genes were then employed to construct a prognostic model that accurately predicts overall survival rates in HCC patients. Our findings revealed a strong correlation between the model's risk scores and tumor microenvironment (TME) status, immune cell infiltration, and immune checkpoint expression. Furthermore, we screened for drugs with potential therapeutic efficacy in high- and low-risk HCC groups. Notably, PPP2R5B gene knockdown was found to inhibit HCC cell proliferation and clonogenic capacity, suggesting its role in HCC progression. In conclusion, this study presents a novel pan-apoptosis gene-based prognostic risk model for HCC, providing valuable insights into patient TME status and guiding the selection of targeted therapies and immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsApoptosisImmunotherapyTumor MicroenvironmentHumansPrognosisGene Expression Regulation, NeoplasticCell Line, TumorProtein Phosphatase 2MaleFemale

Stichwörter der Autor:innen

Hepatocellular carcinomaPan-apoptosisRisk scoresTumor microenvironment

Substanzen

Protein Phosphatase 2

Autor:innen und Institutionen

  • Laboratory of Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China; Hepatobiliary Related Diseases Key Laboratory of Zhanjiang, Zhanjiang, 524001, Guangdong…
  • Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China. Electronic address: 1044486429@qq.com.
  • Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China. Electronic address: 99276298@qq.com.
  • Hepatobiliary Surgery, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China. Electronic address: anwan4571@163.com.
  • Clinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, Guangdong, China. Electronic address: wujiay@gdmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

He, Y., Wu, S., Chen, L., Chen, W., Zhan, X., Li, J., Wang, B., Gao, C., Wu, J., Wang, Q., Li, M., & Liu, B. (2024). Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150633

Vancouver

He Y, Wu S, Chen L, Chen W, Zhan X, Li J, et al. Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150633

BibTeX
@article{He2024,
  author = {He, Yuhong and Wu, Shihao and Chen, Lifan and Chen, Wenxia and Zhan, Xiumei and Li, Jiaxing and Wang, Bingyuan and Gao, Chenfeng and Wu, Jiayuan and Wang, Qingwei and Li, Mingyi and Liu, Bin},
  title = {Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150633}
}
Kostenlos starten →